509 related articles for article (PubMed ID: 16638626)
21. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
[TBL] [Abstract][Full Text] [Related]
22. [Postoperative detection of AFP mRNA in the peripheral blood of hepatic cellular carcinoma patients and its correlation with recurrence].
Zhi H; Zhan J; Deng QL; Huang ZM
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):112-5. PubMed ID: 17645845
[TBL] [Abstract][Full Text] [Related]
23. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.
Tateishi R; Shiina S; Yoshida H; Teratani T; Obi S; Yamashiki N; Yoshida H; Akamatsu M; Kawabe T; Omata M
Hepatology; 2006 Dec; 44(6):1518-27. PubMed ID: 17133456
[TBL] [Abstract][Full Text] [Related]
24. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
[TBL] [Abstract][Full Text] [Related]
25. [AFP mRNA expression in peripheral blood correlates with metastasis of hepatocellular carcinoma].
Jiang Y; Yang Z; Hu J
Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):38-41. PubMed ID: 11776794
[TBL] [Abstract][Full Text] [Related]
26. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320
[TBL] [Abstract][Full Text] [Related]
27. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
[TBL] [Abstract][Full Text] [Related]
28. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L
Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505
[TBL] [Abstract][Full Text] [Related]
29. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis.
Yao F; Guo JM; Xu CF; Lou YL; Xiao BX; Zhou WH; Chen J; Hu YR; Liu Z; Hong GF
Clin Chim Acta; 2005 Nov; 361(1-2):119-27. PubMed ID: 15993394
[TBL] [Abstract][Full Text] [Related]
30. [The influence of tumor cells spreading in blood to relapse and distant metastasis of hepatocellular carcinoma after surgery].
LIU Y; ZHANG GT; WU MC
Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1583-5. PubMed ID: 19094658
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma.
Hayashi K; Kumada T; Nakano S; Takeda I; Sugiyama K; Kiriyama S; Sone Y; Miyata A; Shimizu H; Satomura S
Am J Gastroenterol; 1999 Oct; 94(10):3028-33. PubMed ID: 10520864
[TBL] [Abstract][Full Text] [Related]
32. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
[TBL] [Abstract][Full Text] [Related]
33. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
Huo TI; Huang YH; Lui WY; Wu JC; Lee PC; Chang FY; Lee SD
Oncol Rep; 2004 Feb; 11(2):543-50. PubMed ID: 14719097
[TBL] [Abstract][Full Text] [Related]
34. Monitoring of lectin-reactive alpha-fetoproteins in patients with hepatocellular carcinoma treated using transcatheter arterial embolization.
Yamashita F; Tanaka M; Satomura S; Tanikawa K
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):627-33. PubMed ID: 8590157
[TBL] [Abstract][Full Text] [Related]
35. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.
Wong IH; Lau WY; Leung T; Yeo W; Johnson PJ
Clin Cancer Res; 1999 Dec; 5(12):4021-7. PubMed ID: 10632334
[TBL] [Abstract][Full Text] [Related]
36. Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.
Niwa Y; Matsumura M; Shiratori Y; Imamura M; Kato N; Shiina S; Okudaira T; Ikeda Y; Inoue T; Omata M
Hepatology; 1996 Jun; 23(6):1384-92. PubMed ID: 8675155
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
Farinati F; Marino D; De Giorgio M; Baldan A; Cantarini M; Cursaro C; Rapaccini G; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M; Trevisani F
Am J Gastroenterol; 2006 Mar; 101(3):524-32. PubMed ID: 16542289
[TBL] [Abstract][Full Text] [Related]
38. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
Lao OB; Weissman J; Perkins JD
Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
[TBL] [Abstract][Full Text] [Related]
39. Significance of alpha-fetoprotein mRNA level in hepatocellular carcinoma patients treated with radiofrequency ablation.
Du XL; Ma QJ; Wu T; Bao GQ; Lu JG; Chu YK
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):172-5. PubMed ID: 17374577
[TBL] [Abstract][Full Text] [Related]
40. Albumin mRNA in plasma predicts post-transplant recurrence of patients with hepatocellular carcinoma.
Cheung ST; Fan ST; Lee YT; Chow JP; Ng IO; Fong DY; Lo CM
Transplantation; 2008 Jan; 85(1):81-7. PubMed ID: 18192916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]